The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016
Open accessAbstract
STUDY QUESTION: What is the current status of assisted reproductive technology (ART) service availability, efficacy and safety in mainland China? SUMMARY ANSWER: In this first national report on ART status in mainland China, data on treatment numbers, outcomes and complications in 2016 are provided and analyzed, respectively. WHAT IS KNOWN ALREADY: National ART Service Provision Surveys are conducted in mainland China regularly. Data were analyzed, and this manuscript was written by team members from the National Center for Women and Children’s Health, China CDC and the Department of Women and Children Health, National Health Commission of the People’s Republic of China. STUDY DESIGN, SIZE AND DURATION: A cross-sectional nationwide survey was completed in 2018, in which data regarding ART treatments, performed from 1st January to 31st December2016 in 445 ART clinics located in 31 provinces of mainland China, were collected. PARTICIPANTS/MATERIALS, SETTING AND METHODS: There were in total 451 licensed ART clinics (including artificial insemination clinics) in mainland China in 2016, of which 445 submitted service data. A total of 906 840 cycles were provided by 323 in vitro fertilization (IVF) clinics, involving 375 770 conventional IVF cycles, 154 948 intracytoplasmic sperm injection (ICSI) cycles, 367 146 frozen embryo transfer (FET) thawing cycles and 8976 preimplantation genetic diagnosis (PGD) treatment cycles. A total of 161 376 artificial (i.e. intrauterine) insemination (AI) cycles were reported by 443 clinics, with 126 872 cycles using the husband’s semen (AIH) and 34 504 using donor semen (AID). MAIN RESULTS AND THE ROLE OF CHANCE: In total, 98.7% of the licensed clinics, contributing to 100% of the ART services (including AID and AIH cycles), were included in this report. (Six clinics provided institutional information only and were excluded.) There were 906 840 in vitro fertilization cycles performed in mainland China with a population of over 1.3 billion inhabitants, with cycles per million inhabitants (C/M) increasing from 360 in 2013 to 657 in 2016, nationwide (range among provinces: 45–3676). After treatment with conventional IVF, the clinical pregnancy rate (PR) per oocyte retrieval cycle was 23.2%, the delivery rate (DR) per oocyte retrieval cycle was 18.7% and the proportion of twin delivery among the total deliveries was 27.9%. For ICSI cycles, the PR, DR and TDR were 20.5%, 16.7% and 27.2%, respectively. For FET per thawing cycles, the PR, DR and TDR were 48.2%, 37.6% and 24.2%. For PGD per diagnosis cycles, the PR, DR and TDR were 38.1%, 29.7% and 4.2%. For AIH cycles, the PR and DR were 13.3% and 10.5%; for AID cycles, the PR and DR were 24.3% and 21.1%, respectively. The total number of live infants born in mainland China in 2016, was 18.46 million, and the number of infants born through ART conducted in 2016 was 311 309, which accounted for 1.69% of the total. The reported rate of birth defects was about 87/10 000. The incidence of moderate to severe ovarian hyper-stimulation syndrome (OHSS) was 11.5 per 1000 oocyte retrieval cycles, and other complications were much more rare. LIMITATIONS AND REASONS FOR CAUTION: This report is based on the summary data of ART services provided. The success rates were not calculated by age stratification. A low rate of birth defects was reported, which might be confounded by variations in birth follow-up methods, statistical timing and record taking. WIDER IMPLICATIONS OF THE FINDINGS: ART service availability has improved significantly in recent years in mainland China. Because China is a vast country, significant imbalances in ART service provision do exist; however, the main efficacy and safety indicators were close to those of western countries. TRIAL REGISTRATION NUMBER: N/A STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Key R&D Program of China (2016YFC1000307–2). There are no competing interests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIRTH AFTER THE REIMPLANTATION OF A HUMAN EMBRYO
Steptoe, P. C., & Edwards, R. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92957-4 · Cited by 2,614
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320
ART in Europe, 2014: results generated from European registries by ESHRE†
De Geyter, C., Calhaz-Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., Goossens, V, et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey242 · Cited by 639
Zegers-Hochschild, F., Mansour, R., Ishihara, O., Adamson, G. D., de Mouzon, J., Nygren, K. G., & Sullivan, E. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.005 · Cited by 540
Dyer, S., Chambers, G. M., de Mouzon, J., Nygren, K. G., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Adamson, G. D. (2016) · Human Reproduction · doi:10.1093/humrep/dew082 · Cited by 491
Adamson, G. D., de Mouzon, J., Chambers, G. M., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Dyer, S. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.039 · Cited by 385
Assisted Reproductive Technology Surveillance — United States, 2015
Sunderam, S., Kissin, D. M., Crawford, S. B., Folger, S. G., Boulet, S. L., Warner, L., & Barfield, W. D. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6703a1 · Cited by 210
Assisted Reproductive Technology Surveillance — United States, 2016
Sunderam, S., Kissin, D. M., Zhang, Y., Folger, S. G., Boulet, S. L., Warner, L., Callaghan, W. M., & Barfield, W. D. (2019) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6804a1 · Cited by 182
Irahara, M., Kuwahara, A., Iwasa, T., Ishikawa, T., Ishihara, O., Kugu, K., Sawa, R., Banno, K., & Saito, H. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12014 · Cited by 133
Assisted reproductive technology in China: compliance and non-compliance.
Qiao, J., & Feng, H. L. (2014) · PubMed · doi:10.3978/j.issn.2224-4336.2014.01.06 · Cited by 105
Research works printed but not linked: 1
- Wang, 2016, The time and space differences of China's agricultural structure characteristics of the carbon emissions and study, The World of Survey and Research, 9, 3
Cited by
Qiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32708-2 · Cited by 569
Self-citationChambers, G. M., Dyer, S., Zegers-Hochschild, F., de Mouzon, J., Ishihara, O., Banker, M., Mansour, R., Kupka, M. S., & Adamson, G. D. (2021) · Human Reproduction · doi:10.1093/humrep/deab198 · Cited by 298
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“China has just begun reporting utilization rates of 657 per million for 2017 (Bai et al. , 2020).”
BackgroundThe Future of IVF: The New Normal in Human Reproduction
Kushnir, V. A., Smith, G. D., & Adashi, E. Y. (2022) · Reproductive Sciences · doi:10.1007/s43032-021-00829-3 · Cited by 133
Prevalence and associated factors of infertility among 20–49 year old women in Henan Province, China
Liang, S., Chen, Y., Wang, Q., Chen, H., Cui, C., Xu, X., Zhang, Q., & Zhang, C. (2021) · Reproductive Health · doi:10.1186/s12978-021-01298-2 · Cited by 127
Metadata
- Authors
- Bai, F., Wang, D. Y., Fan, Y. J., Qiu, J., Wang, L., Dai, Y., & Song, L.
- Affiliations
- National Center for Women and Children’s Health, China CDC (CN)
- National Health and Family Planning Commission (CN)
- Corresponding author
- Song, L
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02
- Volume
- 35
- Issue
- 2
- Pages
- 446-452
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W3004948551
- Cited by
- 150
- References
- 12
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 23 · 2023: 27 · 2022: 33 · 2021: 23 · 2020: 9
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development of China (2016YFC1000307–2)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- assisted reproduction, in vitro fertilization, intracytoplasmic sperm injection, frozen embryo transfer, preimplantation genetic diagnosis, artificial insemination, ART outcomes, mainland China, ART regulation, infertility treatment
- MeSH terms
- Child, China, Cross-Sectional Studies, Female, Fertilization in Vitro, Humans, Pregnancy, Pregnancy Outcome, Registries, Pregnancy Rate, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016. https://app.cochat.ai/papers/10.1093/humrep/dez245
- The paper
- Bai, F., Wang, D. Y., Fan, Y. J., Qiu, J., Wang, L., Dai, Y., & Song, L. (2020). Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016. Human Reproduction. https://doi.org/10.1093/humrep/dez245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.